Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
bpost stock logo
BPOSY
bpost
$2.57
$1.85
$2.57
$2.72
$514M0.8420 shsN/A
Jungheinrich AG stock logo
JGHAF
Jungheinrich
$44.11
$40.21
$24.70
$44.11
$2.38B0.445 shsN/A
Nihon Kohden Corporation stock logo
NHNKY
Nihon Kohden
$13.72
+16.2%
$12.25
$9.86
$20.00
$2.35B0.354,153 shs3,310 shs
Pharma Mar stock logo
PHMMF
Pharma Mar
$92.57
$92.98
$34.26
$105.60
N/A0.22,596 shs2,500 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
bpost stock logo
BPOSY
bpost
0.00%0.00%+65.81%+65.81%-18.41%
Jungheinrich AG stock logo
JGHAF
Jungheinrich
0.00%0.00%0.00%+19.22%+65.21%
Nihon Kohden Corporation stock logo
NHNKY
Nihon Kohden
0.00%+14.91%+4.52%+6.27%-3.11%
Pharma Mar stock logo
PHMMF
Pharma Mar
0.00%0.00%-10.65%+4.97%+170.20%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
bpost stock logo
BPOSY
bpost
N/AN/AN/AN/AN/AN/AN/AN/A
Jungheinrich AG stock logo
JGHAF
Jungheinrich
N/AN/AN/AN/AN/AN/AN/AN/A
Nihon Kohden Corporation stock logo
NHNKY
Nihon Kohden
2.218 of 5 stars
0.05.01.70.02.60.01.3
Pharma Mar stock logo
PHMMF
Pharma Mar
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
bpost stock logo
BPOSY
bpost
0.00
N/AN/AN/A
Jungheinrich AG stock logo
JGHAF
Jungheinrich
4.00
Strong BuyN/AN/A
Nihon Kohden Corporation stock logo
NHNKY
Nihon Kohden
0.00
N/AN/AN/A
Pharma Mar stock logo
PHMMF
Pharma Mar
4.00
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
bpost stock logo
BPOSY
bpost
$4.68B0.11$4.21 per share0.61$4.65 per share0.55
Jungheinrich AG stock logo
JGHAF
Jungheinrich
$5.84B0.41$15.16 per share2.91$48.82 per share0.90
Nihon Kohden Corporation stock logo
NHNKY
Nihon Kohden
$1.48B1.58$0.66 per share20.87$7.00 per share1.96
Pharma Mar stock logo
PHMMF
Pharma Mar
$189.23MN/A$0.41 per share223.50$11.62 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
bpost stock logo
BPOSY
bpost
-$221.94M-$1.36N/AN/A-5.69%7.45%1.45%7/31/2025 (Estimated)
Jungheinrich AG stock logo
JGHAF
Jungheinrich
$312.72MN/A0.00N/AN/AN/AN/A8/8/2025 (Estimated)
Nihon Kohden Corporation stock logo
NHNKY
Nihon Kohden
$93.05M$0.5624.50N/A6.23%7.20%5.43%7/31/2025 (Estimated)
Pharma Mar stock logo
PHMMF
Pharma Mar
$28.27MN/A0.00N/AN/AN/AN/A7/28/2025 (Estimated)

Latest BPOSY, PHMMF, NHNKY, and JGHAF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q4 2025
Nihon Kohden Corporation stock logo
NHNKY
Nihon Kohden
N/A$0.18N/A$0.24N/A$439.11 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
bpost stock logo
BPOSY
bpost
$0.072.72%N/AN/A N/A
Jungheinrich AG stock logo
JGHAF
Jungheinrich
N/AN/AN/AN/AN/A
Nihon Kohden Corporation stock logo
NHNKY
Nihon Kohden
$0.261.90%N/A46.43%N/A
Pharma Mar stock logo
PHMMF
Pharma Mar
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
bpost stock logo
BPOSY
bpost
2.84
0.98
0.96
Jungheinrich AG stock logo
JGHAF
Jungheinrich
N/A
1.43
1.02
Nihon Kohden Corporation stock logo
NHNKY
Nihon Kohden
N/A
2.53
1.76
Pharma Mar stock logo
PHMMF
Pharma Mar
0.20
2.97
2.33

Institutional Ownership

CompanyInstitutional Ownership
bpost stock logo
BPOSY
bpost
N/A
Jungheinrich AG stock logo
JGHAF
Jungheinrich
N/A
Nihon Kohden Corporation stock logo
NHNKY
Nihon Kohden
0.10%
Pharma Mar stock logo
PHMMF
Pharma Mar
N/A

Insider Ownership

CompanyInsider Ownership
bpost stock logo
BPOSY
bpost
N/A
Jungheinrich AG stock logo
JGHAF
Jungheinrich
N/A
Nihon Kohden Corporation stock logo
NHNKY
Nihon Kohden
N/A
Pharma Mar stock logo
PHMMF
Pharma Mar
1.88%
CompanyEmployeesShares OutstandingFree FloatOptionable
bpost stock logo
BPOSY
bpost
32,723200.00 millionN/ANot Optionable
Jungheinrich AG stock logo
JGHAF
Jungheinrich
20,92254.00 millionN/ANot Optionable
Nihon Kohden Corporation stock logo
NHNKY
Nihon Kohden
6,114170.96 millionN/ANot Optionable
Pharma Mar stock logo
PHMMF
Pharma Mar
509N/AN/ANot Optionable

Recent News About These Companies

Pharma Mar’s Strategic Shareholder Meeting
ASCO 25: Jazz, PharmaMar reveal SCLC survival data
Exploring High Growth Tech Stocks In Europe May 2025
Exploring High Growth Tech Stocks in Europe April 2025
Pharma Mar Releases 2024 Director Remuneration Report
High Growth Tech Leads These 3 Top Stocks with Potential
3 Stocks Estimated To Be Up To 48% Below Intrinsic Value
Insider-Led Growth Stocks To Watch In December 2024
Pharma Mar S.A. Reduces Share Capital by Canceling Shares
Pharma Mar Achieves Legal Win in Aplidin Case
PharmaMar gets $10 million milestone from Janssen for Yondelis

Media Sentiment Over Time

bpost stock logo

bpost OTCMKTS:BPOSY

$2.57 0.00 (0.00%)
As of 07/3/2025

bpost NV/SA, together with its subsidiaries, provides mail and parcel services to individuals, businesses, and public institutions in Belgium, rest of Europe, the United States, and internationally. It operates through Belgium, E-Logistics Eurasia, and E-Logistics North America segments. The company offers collection, transport, sorting, and distribution of addressed and non-addressed mail, printed documents, newspapers, periodicals, and parcels, as well as banking and financial products, e-commerce logistics, express delivery, and related services. It also provides transactional mails, advertising mails, press, domestic and international parcels, and logistic solutions; e-commerce fulfilment, including warehousing and handling of goods; e-commerce cross-border services, including custom duties services; operational back-office services, including call center, payment and financial, fraud and tax, administrative and document management services; and proximity and convenience services, such as the access to the network and over-the-counter service for different partners and sale of self-produced goods, as well as retail products and goods of partners, including bpost bank products; repair of electronics; and import services. The company was founded in 1830 and is headquartered in Brussels, Belgium.

Jungheinrich stock logo

Jungheinrich OTCMKTS:JGHAF

$44.11 0.00 (0.00%)
As of 07/3/2025

Jungheinrich Aktiengesellschaft, through its subsidiaries, provides products and solutions for the intralogistics sector with a portfolio of material handling equipment, automated systems, and matching services worldwide. It operates in two segments, Intralogistics and Financial Services. The Intralogistics segment engages in the development, production, sale, and short-term rental of new material handling equipment and warehousing equipment products, including automation; sale and short-term leasing of used trucks; and provides spare parts, as well as maintenance and repair services. The Financial Services segment engages in the sales financing and usage transfer of material handling and warehousing equipment products. The company's products include electric and hand pallet trucks, electric pallet stackers; order pickers; reach trucks; very narrow aisle trucks and EKX cold store high rack stacker; electric forklift; tow tractors, tugger train trailers, shuttles, and used forklift trucks. It also offers rental of fleet, and battery and charger; contract and event hire service; automated guided vehicles, conveyor technology, and stacker cranes; lithium-ion and lead-acid batteries; charging technology; powertrain solutions; electric drives/drivetrains; controllers; electromechanics components/control pedals/displays; electric mounting panels; and cable sets. In addition, the company provides warehouse racking and storage services; digital products and software solutions, including warehouse management system, fleet management system, device and process management solutions, and interface management; and wi-fi infrastructure, barcode scanners, and mobile workstations; as well as develops software applications. It distributes its products through its direct sales and service network, as well as through dealers. Jungheinrich Aktiengesellschaft was founded in 1953 and is headquartered in Hamburg, Germany.

Nihon Kohden stock logo

Nihon Kohden OTCMKTS:NHNKY

$13.72 +1.91 (+16.17%)
As of 07/3/2025 12:17 PM Eastern

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.

Pharma Mar stock logo

Pharma Mar OTCMKTS:PHMMF

$92.57 0.00 (0.00%)
As of 07/3/2025

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.